These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15133777)

  • 21. A proposal for radical changes in the drug-approval process.
    Wood AJ
    N Engl J Med; 2006 Aug; 355(6):618-23. PubMed ID: 16899784
    [No Abstract]   [Full Text] [Related]  

  • 22. Can open-source R&D reinvigorate drug research?
    Munos B
    Nat Rev Drug Discov; 2006 Sep; 5(9):723-9. PubMed ID: 16915233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying quality leads - an important factor in reducing attrition of clinical candidates.
    Chackalamannil S; Desai MC
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):381-2. PubMed ID: 17659478
    [No Abstract]   [Full Text] [Related]  

  • 24. Drive for drugs leads to baby clinical trials.
    Nature; 2006 Mar; 440(7083):406-7. PubMed ID: 16554774
    [No Abstract]   [Full Text] [Related]  

  • 25. Dosing strategies for antidepressant clinical trials: a commentary.
    Robinson DS; Khan A
    J Clin Psychopharmacol; 2004 Feb; 24(1):1-3. PubMed ID: 14709939
    [No Abstract]   [Full Text] [Related]  

  • 26. The seduction of biomarkers in the practice of medicine and the tyranny of power in the drug approval process: lessons from niacin.
    Lehmann DF; Sitar DS
    J Clin Pharmacol; 2011 Nov; 51(11):1496-8. PubMed ID: 21998350
    [No Abstract]   [Full Text] [Related]  

  • 27. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

  • 28. Patient recruitment and compliance issues in clinical trials.
    Cramer JA
    Epilepsy Res Suppl; 1993; 10():211-22. PubMed ID: 8251099
    [No Abstract]   [Full Text] [Related]  

  • 29. Dynavax trial halted.
    DeFrancesco L
    Nat Biotechnol; 2008 May; 26(5):484. PubMed ID: 18464766
    [No Abstract]   [Full Text] [Related]  

  • 30. Uncertainty surrounds cancer vaccine review at FDA.
    Fox JL
    Nat Biotechnol; 2007 Aug; 25(8):827-8. PubMed ID: 17687346
    [No Abstract]   [Full Text] [Related]  

  • 31. Is it time to rethink the expanded-access programs for HIV infection?
    Amorosa V; Tebas P
    J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuft's report backs FDA fast-track, but post-marketing concerns loom.
    Vastag B
    Nat Biotechnol; 2006 May; 24(5):478. PubMed ID: 16680113
    [No Abstract]   [Full Text] [Related]  

  • 33. From proposal to patient: how CMS makes coverage decisions.
    Turnbull GB
    Ostomy Wound Manage; 2002 Apr; 48(4):8-10, 82. PubMed ID: 11993063
    [No Abstract]   [Full Text] [Related]  

  • 34. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug testing from a patient's perspective.
    Stehlin IB
    FDA Consum; 1995 Mar; 29(2):6-7. PubMed ID: 10143664
    [No Abstract]   [Full Text] [Related]  

  • 36. HDAC inhibitors overcome first hurdle.
    Garber K
    Nat Biotechnol; 2007 Jan; 25(1):17-9. PubMed ID: 17211382
    [No Abstract]   [Full Text] [Related]  

  • 37. Accelerated approval of oncology products: a decade of experience.
    Dagher R; Johnson J; Williams G; Keegan P; Pazdur R
    J Natl Cancer Inst; 2004 Oct; 96(20):1500-9. PubMed ID: 15494600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process.
    Roden DM; Temple R
    Circulation; 2005 Apr; 111(13):1697-702. PubMed ID: 15811869
    [No Abstract]   [Full Text] [Related]  

  • 39. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.
    Ichimaru K; Toyoshima S; Uyama Y
    Clin Pharmacol Ther; 2010 Mar; 87(3):362-6. PubMed ID: 20107436
    [No Abstract]   [Full Text] [Related]  

  • 40. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.